A patient with a newly diagnosed Bipolar II disorder is transitioning from sertraline to a mood stabilizer. Which nursing intervention is most important to prioritize during this medication change?

B) Monitor the patient for signs of lithium toxicity, especially during the initial phase of treatment.

A) Educate the patient about the potential weight gain associated with mood stabilizers.

B) Monitor the patient for signs of lithium toxicity, especially during the initial phase of treatment.

C) Encourage the patient to maintain a regular sleep schedule to prevent mood destabilization.

D) Assess the patient’s adherence to the prescribed medication regimen during follow-up visits.

A patient with a new diagnosis of Bipolar II disorder is being transitioned from sertraline to a mood stabilizer. Which nursing intervention is most critical during this medication adjustment period?

D) Evaluate the patient's mood stability and monitor for the emergence of manic or depressive episodes.

A) Educate the patient about the importance of adherence to the new medication regimen.

B) Monitor the patient for signs of serotonin syndrome, including agitation and confusion.

C) Assess the patient for withdrawal symptoms associated with SSRI tapering, such as dizziness and flu-like symptoms.

D) Evaluate the patient's mood stability and monitor for the emergence of manic or depressive episodes.

A nurse is caring for a patient with bipolar disorder who has recently started on lithium and aripiprazole therapy. The patient reports mild tremors and increased thirst. What is the nurse's priority action?

B) Check the patient's serum lithium level and notify the healthcare provider.

A) Reassure the patient that these are normal side effects and will subside.

B) Check the patient's serum lithium level and notify the healthcare provider.

C) Encourage the patient to increase fluid intake to manage thirst.

D) Schedule an appointment for the patient to discuss these symptoms with a psychiatrist.

A patient undergoing treatment with lithium for bipolar disorder presents with mild tremors and increased thirst. The healthcare provider orders a serum lithium level, which returns at 1.3 mEq/L. Which nursing intervention is most appropriate based on this information?

B) Educate the patient on the signs of lithium toxicity and reduce the lithium dose as prescribed.

A) Continue the current dose of lithium and monitor for further side effects.

B) Educate the patient on the signs of lithium toxicity and reduce the lithium dose as prescribed.

C) Discontinue the lithium immediately and notify the healthcare provider.

D) Increase fluid intake to dilute the serum lithium concentration.

A patient being treated for bipolar disorder with lithium presents with fatigue, muscle weakness, frequent urination, and a slight hand tremor. Lab results show a serum lithium level of 1.0 mEq/L, mild hyponatremia, and subclinical hypothyroidism. What is the most appropriate nursing intervention to address the patient's current symptoms?

B) Educate the patient on the importance of regular thyroid function monitoring and follow up with an endocrinologist.

A) Encourage increased water intake to manage frequent urination and prevent dehydration.

B) Educate the patient on the importance of regular thyroid function monitoring and follow up with an endocrinologist.

C) Increase dietary sodium intake to address hyponatremia and monitor for changes in symptoms.

D) Suggest the addition of a beta-blocker to manage the hand tremor and reduce muscle weakness.

A patient with bipolar disorder is experiencing fatigue, muscle weakness, frequent urination, and a hand tremor despite a therapeutic serum lithium level. The lab results show mild hyponatremia and subclinical hypothyroidism. Which nursing intervention is most appropriate to address the patient's symptoms and minimize adverse effects?

C) Educate the patient on taking thyroid hormone replacement as prescribed by the endocrinologist.

A) Encourage the patient to increase fluid intake to manage frequent urination.

B) Recommend a low-sodium diet to correct hyponatremia.

C) Educate the patient on taking thyroid hormone replacement as prescribed by the endocrinologist.

D) Advise the patient to stop lithium therapy until symptoms resolve.

A patient with subclinical hypothyroidism who is being treated for bipolar disorder with lithium presents with increased palpitations and dizziness. An ECG shows sinus tachycardia. Which nursing intervention is most appropriate to prioritize for this patient?

B) Monitor lithium levels closely and assess for signs of lithium toxicity.

A) Encourage increased fluid intake to prevent dehydration.

B) Monitor lithium levels closely and assess for signs of lithium toxicity.

C) Educate the patient on dietary iodine intake to support thyroid function.

D) Advise the patient to decrease physical activity to reduce cardiac workload.

A patient with subclinical hypothyroidism and a history of bipolar disorder on lithium therapy is experiencing palpitations and dizziness. The healthcare team has initiated low-dose levothyroxine. As the nurse, what is the most appropriate action to take to monitor for potential complications from the new treatment plan?

A) Monitor the patient's heart rate and blood pressure regularly to assess for cardiovascular changes.

B) Increase the frequency of lithium level checks to ensure therapeutic levels are maintained.

C) Educate the patient on the importance of maintaining consistent fluid and sodium intake.

D) Encourage the patient to increase physical activity to help manage tremors.

A patient with a history of bipolar disorder and subclinical hypothyroidism has been recently started on low-dose levothyroxine. She reports anxiety, restlessness, palpitations, nausea, and occasional vomiting. Her TSH levels are near the lower end of the normal range, and her lithium levels are slightly elevated. What is the most appropriate nursing intervention to prioritize for this patient?

A) Educate the patient about potential side effects of levothyroxine and lithium, emphasizing the importance of adhering to follow-up appointments.

B) Encourage the patient to increase dietary iodine to help stabilize thyroid function.

C) Advise the patient to stop taking levothyroxine until symptoms resolve.

D) Suggest the patient take an over-the-counter antacid to relieve gastrointestinal symptoms.

A patient on low-dose levothyroxine and lithium presents with anxiety, restlessness, palpitations, mild nausea, and occasional vomiting. Recent lab results show a decrease in TSH levels and a lithium serum concentration of 1.3 mEq/L. Which nursing intervention is most appropriate to address the current clinical findings?

B) Educate the patient on the importance of adhering to the prescribed lithium dosage and schedule.

A) Increase the levothyroxine dose to further decrease the TSH level.

B) Educate the patient on the importance of adhering to the prescribed lithium dosage and schedule.

C) Advise the patient to increase dietary iodine intake to improve thyroid function.

D) Recommend a consultation with a dietitian to address potential dietary triggers for gastrointestinal symptoms.

Misdiagnosed Major Depression Revealed as Bipolar Disorder After SSRI-Induced Mania - Nursing Case Study

Pathophysiology

• Primary mechanism: SSRIs increase serotonin levels, which can unmask underlying bipolar disorder by triggering manic episodes in predisposed individuals, highlighting a shift from unipolar to bipolar diagnosis.

• Secondary mechanism: The manic episode indicates dysregulation in neurotransmitter systems beyond serotonin, including dopamine, which plays a role in mood stabilization and is often implicated in bipolar disorder.

• Key complication: Misdiagnosis and inappropriate treatment with SSRIs in bipolar disorder can lead to rapid cycling and worsening of mood instability, necessitating a revised treatment plan focusing on mood stabilization.

Patient Profile

Demographics:

35-year-old female, graphic designer

History:

• Key past medical history: Diagnosed with Major Depression two years ago, anxiety disorder, family history of bipolar disorder

• Current medications: Sertraline 100 mg daily, lorazepam 1 mg as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe mood swings and periods of high energy followed by depressive episodes

• Key symptoms: Irritability, decreased need for sleep, increased talkativeness, racing thoughts, impulsivity, persistent sadness, fatigue

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 20 breaths per minute, temperature 98.9°F

Section 1

New Diagnostic Results:

Following the concerning presentation of mood instability and the patient's family history of bipolar disorder, the healthcare team decided to conduct a comprehensive psychiatric evaluation and adjust the diagnostic approach. The patient underwent a detailed mental status examination, revealing a marked increase in goal-directed activity and elevated mood alternating with periods of profound sadness and fatigue, consistent with hypomanic episodes. Additionally, lab tests were ordered to rule out secondary causes of mood swings, including a thyroid panel, complete blood count (CBC), and metabolic panel. Thyroid function tests returned normal, and there were no significant abnormalities in the CBC or metabolic panel to suggest an endocrine or metabolic cause for her symptoms.

A thorough evaluation using the Mood Disorder Questionnaire (MDQ) indicated a high likelihood of bipolar disorder, revealing a history of episodic mood elevations that align with the diagnostic criteria for Bipolar II disorder. Neuroimaging studies, such as an MRI, showed no structural brain abnormalities but underscored the need for careful monitoring of neurochemical imbalances, potentially exacerbated by the current SSRI treatment.

Based on these findings, the healthcare team re-evaluated the patient's treatment plan, recognizing the need to discontinue sertraline to prevent further SSRI-induced mania. A gradual tapering of the SSRI was initiated, with plans to introduce a mood stabilizer, such as lithium or valproate, to manage the bipolar symptoms effectively. The team also recommended an adjunctive low-dose atypical antipsychotic to address the acute manic symptoms, emphasizing the importance of close monitoring for any adverse effects. These diagnostic results and subsequent treatment adjustments set the stage for evaluating the patient's response to the new therapeutic strategy and the potential emergence of new complications.

Section 2

Response to Interventions:

Following the adjustment of the treatment plan, the patient was carefully monitored in an outpatient setting to assess her response to the newly introduced mood stabilizer, lithium, and the adjunctive low-dose atypical antipsychotic, aripiprazole. During the first week, the patient reported a noticeable reduction in the intensity and frequency of manic episodes, with a gradual stabilization of mood swings. However, the healthcare team observed mild tremors and increased thirst, prompting a check of lithium levels. The serum lithium concentration was 1.3 mEq/L, slightly above the therapeutic range, necessitating a minor dose adjustment to avoid potential toxicity.

Vital signs remained stable, with blood pressure at 118/76 mmHg, heart rate at 78 bpm, and temperature at 98.6°F. The patient also reported improved sleep patterns and decreased anxiety, though still experienced intermittent episodes of fatigue. The aripiprazole was well-tolerated with no significant side effects noted, indicating that this combination of medications was beginning to create a more balanced mood state without triggering additional complications.

As the treatment progressed, the patient began engaging more actively in cognitive behavioral therapy (CBT) sessions, which were introduced as part of a comprehensive management plan. The therapy focused on developing coping strategies for mood fluctuations and improving overall stress management. The patient's family was also involved in psychoeducation sessions to better understand bipolar disorder, emphasizing the importance of medication adherence and recognizing early signs of mood changes. These interventions together fostered a supportive environment, crucial for long-term management and reducing the risk of future episodes. The healthcare team remained vigilant for any new or worsening symptoms, ensuring timely adjustments to the treatment plan as needed.

Section 3

New Complications:

Two weeks into the adjusted treatment regimen, the patient began experiencing new symptoms that required immediate attention. Despite the initial stabilization of mood, she reported increasing levels of fatigue and muscle weakness, which were concerning given her recent progress. Additionally, she noticed frequent urination and a slight hand tremor that persisted despite the previous dose adjustment of lithium. In response, the healthcare team conducted a thorough clinical assessment and ordered a panel of laboratory tests to investigate potential underlying causes.

The lab results revealed a serum lithium level of 1.0 mEq/L, now within the therapeutic range, suggesting that lithium toxicity was unlikely. However, a comprehensive metabolic panel indicated the presence of mild hyponatremia, with a serum sodium level of 132 mEq/L. This electrolyte imbalance, while not severe, could be contributing to the patient's fatigue and generalized weakness. Furthermore, thyroid function tests showed signs of subclinical hypothyroidism, with a slightly elevated TSH level at 5.5 mIU/L, a known potential side effect of lithium therapy.

Recognizing the need for a multidisciplinary approach, the healthcare team decided to consult an endocrinologist to address the thyroid irregularities. Simultaneously, they considered adjusting the patient's fluid intake and planned a review of her medications to ensure optimal management of her bipolar disorder while minimizing adverse effects. Continued monitoring of electrolytes and thyroid function was deemed essential, with the aim of preventing further complications as the patient continued her therapeutic journey. The focus remained on maintaining mood stability while ensuring comprehensive management of her physical health, highlighting the interconnected nature of psychiatric and physiological well-being.

Section 4

New Complications:

As the healthcare team continued to monitor the patient's condition, new complications emerged, necessitating further clinical reasoning and adjustments to her treatment plan. Despite addressing the mild hyponatremia with careful management of her fluid intake, the patient began to experience increased palpitations and intermittent dizziness. Her vital signs during this period were notable for a slightly elevated heart rate at 102 beats per minute, with a blood pressure reading of 112/76 mmHg, which, although within normal limits, showed a trend towards orthostatic changes when she moved from lying down to standing.

In light of these developments, the healthcare team ordered additional diagnostic tests, including an ECG, which revealed a sinus tachycardia but no other significant abnormalities. The patient's symptoms could potentially be attributed to the subclinical hypothyroidism, given the known cardiovascular effects of thyroid hormone imbalances. Additionally, the persistent hand tremor raised concerns about the fine balance required in managing her lithium levels, suggesting the need for close monitoring to avoid the resurgence of manic symptoms or the onset of further neurological side effects.

The team decided to initiate low-dose levothyroxine to address the subclinical hypothyroidism, with a plan for gradual titration based on the patient's response and repeat thyroid function tests. This decision was made in consultation with the endocrinologist, who recommended close follow-up to ensure that the introduction of thyroid hormone replacement did not exacerbate her psychiatric symptoms or introduce new complications. The holistic approach emphasized the importance of integrating psychiatric and medical care, recognizing the intricate interplay between the patient's mental health and physiological condition, and setting the stage for ongoing assessment and adaptation of her treatment plan.

Section 5

In response to the initiation of low-dose levothyroxine, the patient showed some initial improvement in energy levels, but new complications arose that warranted further investigation. Within a week, she reported experiencing heightened anxiety and restlessness, coupled with increased frequency of palpitations. Her follow-up thyroid function tests indicated a slight improvement, with her TSH levels decreasing towards the lower end of the normal range. However, these symptoms suggested a possible overshoot in her thyroid hormone levels, leading the healthcare team to consider the delicate balance between correcting her subclinical hypothyroidism and avoiding hyperthyroid-like symptoms.

Simultaneously, the patient experienced mild gastrointestinal disturbances, including nausea and occasional vomiting. A review of her medication regimen and recent dietary intake did not immediately reveal any likely culprits, prompting the team to re-evaluate her lithium levels, considering its narrow therapeutic index and potential for gastrointestinal side effects. The lithium serum concentration came back slightly elevated at 1.3 mEq/L, just above the therapeutic range, necessitating an adjustment in her lithium dosage. The team decided to decrease the lithium dose carefully while maintaining close monitoring of her psychiatric status and electrolyte levels to prevent a relapse of manic symptoms or further complications.

Throughout this period, the interdisciplinary team emphasized the importance of patient education, ensuring the patient understood the potential side effects and the importance of adhering closely to follow-up appointments and recommended lifestyle modifications. This approach aimed to empower the patient in her care, fostering an understanding of the complex interplay between her psychiatric and medical conditions, and preparing her for the possibility of further adjustments in her treatment plan as her condition evolved. As the patient's journey continued, the focus remained on achieving stability through a nuanced, patient-centered approach that integrated both medical and psychiatric care.